Clinical trials
Not yet recruiting Phase 2 Triple Negative Breast Neoplasms trials
Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.
47 trials match Source: ClinicalTrials.gov registrations
Trials started per year
By phase, 2000 to 2026.
| Category | Trials |
|---|---|
| 2022 | 1 |
| 2023 | 1 |
| 2024 | 8 |
| 2025 | 14 |
| 2026 | 21 |
Status
Trials by registry status. Select a bar to filter.
| Category | Trials |
|---|---|
| Not yet recruiting | 47 |
Top lead sponsors
A sponsor with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Fudan University | 6 |
| Cancer Institute and Hospital, Chinese Academy of Medical Sciences | 3 |
| Tianjin Medical University Cancer Institute and Hospital | 3 |
| Henan Cancer Hospital | 2 |
| Shengjing Hospital | 2 |
| Xijing Hospital | 2 |
| AHS Cancer Control Alberta | 1 |
| Emory University | 1 |
| First Hospital of China Medical University | 1 |
| Fundacao Champalimaud | 1 |
Top conditions
MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Triple Negative Breast Neoplasms | 47 |
| Breast Neoplasms | 10 |
| Uterine Cervical Neoplasms | 3 |
| Colorectal Neoplasms | 2 |
| Small Cell Lung Carcinoma | 2 |
| Brain Neoplasms | 1 |
| Carcinoma, Hepatocellular | 1 |
| Carcinoma, Non-Small-Cell Lung | 1 |
| Carcinoma, Renal Cell | 1 |
| Cholangiocarcinoma | 1 |
Trials
Showing 1 to 25 of 47. Each trial links to its page on Pharma Observatory.
Recently changed trials
Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.
No changes to these trials in the last 7 days.
Go deeper on Pharma Observatory
Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.